{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:05:47Z","timestamp":1790712347622,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T00:00:00Z","timestamp":1734220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017447","name":"Alliance Program in Shanghai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015796","name":"Shanghai Lingjun Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015796","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201392"],"award-info":[{"award-number":["82201392"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.tjpad.2024.100040","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T02:23:48Z","timestamp":1736043828000},"page":"100040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Distinct CSF \u03b1-synuclein aggregation profiles associated with Alzheimer's disease phenotypes and MCI-to-AD conversion"],"prefix":"10.1016","volume":"12","author":[{"given":"Yanfei","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingbing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9924-3763","authenticated-orcid":false,"given":"Aonan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.tjpad.2024.100040_bib0001","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","article-title":"The precursor protein of non-a beta component of alzheimer's disease amyloid is a presynaptic protein of the central nervous system","volume":"14","author":"Iwai","year":"1995","journal-title":"Neuron"},{"issue":"20","key":"10.1016\/j.tjpad.2024.100040_bib0002","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1523\/JNEUROSCI.22-20-08797.2002","article-title":"Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein","volume":"22","author":"Cabin","year":"2002","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100040_bib0003","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of \u03b1-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.tjpad.2024.100040_bib0004","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1101\/sqb.2012.76.010637","article-title":"The heat shock response: systems biology of proteotoxic stress in aging and disease","volume":"76","author":"Morimoto","year":"2011","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"34","key":"10.1016\/j.tjpad.2024.100040_bib0005","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","article-title":"Different species of alpha-synuclein oligomers induce calcium influx and seeding","volume":"27","author":"Danzer","year":"2007","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.tjpad.2024.100040_bib0006","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.biocel.2009.05.008","article-title":"Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells","volume":"41","author":"Parihar","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"issue":"10","key":"10.1016\/j.tjpad.2024.100040_bib0007","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1073\/pnas.1218424110","article-title":"Large \u03b1-synuclein oligomers inhibit neuronal snare-mediated vesicle docking","volume":"110","author":"Choi","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10284","key":"10.1016\/j.tjpad.2024.100040_bib0008","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.tjpad.2024.100040_bib0009","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1212\/WNL.0000000000001834","article-title":"Mixed pathology is more likely in black than white decedents with alzheimer dementia","volume":"85","author":"Barnes","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.tjpad.2024.100040_bib0010","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1212\/WNL.51.2.351","article-title":"Cognitive decline is faster in lewy body variant than in alzheimer's disease","volume":"51","author":"Olichney","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2024.100040_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2024.08.003","article-title":"Gut-induced alpha-synuclein and tau propagation initiate parkinson's and alzheimer's disease co-pathology and behavior impairments","author":"Xiang","year":"2024","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.tjpad.2024.100040_bib0012","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/alz.12204","article-title":"An examination of a novel multipanel of csf biomarkers in the alzheimer's disease clinical and pathological continuum","volume":"17","author":"Van Hulle","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.tjpad.2024.100040_bib0013","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","article-title":"Direct quantification of csf alpha-synuclein by elisa and first cross-sectional study in patients with neurodegeneration","volume":"213","author":"Mollenhauer","year":"2008","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100040_bib0014","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/ene.14032","article-title":"The value of cerebrospinal fluid \u03b1-synuclein and the tau\/\u03b1-synuclein ratio for diagnosis of neurodegenerative disorders with lewy pathology","volume":"27","author":"F\u00f8rland","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.tjpad.2024.100040_bib0015","doi-asserted-by":"crossref","first-page":"40263","DOI":"10.1038\/srep40263","article-title":"Increased levels of csf total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable alzheimer's disease","volume":"7","author":"Majbour","year":"2017","journal-title":"Sci Rep"},{"issue":"30","key":"10.1016\/j.tjpad.2024.100040_bib0016","doi-asserted-by":"crossref","first-page":"10253","DOI":"10.1523\/JNEUROSCI.0581-12.2012","article-title":"Soluble \u03b1-synuclein is a novel modulator of alzheimer's disease pathophysiology","volume":"32","author":"Larson","year":"2012","journal-title":"J Neurosci"},{"issue":"23","key":"10.1016\/j.tjpad.2024.100040_bib0017","doi-asserted-by":"crossref","first-page":"E4648","DOI":"10.1073\/pnas.1704698114","article-title":"Selective lowering of synapsins induced by oligomeric \u03b1-synuclein exacerbates memory deficits","volume":"114","author":"Larson","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100040_bib0018","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s40478-018-0624-z","article-title":"The relevance of cerebrospinal fluid \u03b1-synuclein levels to sporadic and familial alzheimer's disease","volume":"6","author":"Twohig","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"10.1016\/j.tjpad.2024.100040_bib0019","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3233\/JAD-171013","article-title":"A longitudinal study of total and phosphorylated \u03b1-synuclein with other biomarkers in cerebrospinal fluid of alzheimer's disease and mild cognitive impairment","volume":"61","author":"Wang","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100040_bib0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3233\/JAD-181152","article-title":"Cerebrospinal fluid and plasma biomarkers in neurodegenerative diseases","volume":"68","author":"Seino","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"10.1016\/j.tjpad.2024.100040_bib0021","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jalz.2018.02.015","article-title":"Cerebrospinal fluid \u03b1-synuclein contributes to the differential diagnosis of alzheimer's disease","volume":"14","author":"Shi","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"7794","key":"10.1016\/j.tjpad.2024.100040_bib0022","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating \u03b1-synuclein strains in parkinson's disease and multiple system atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"issue":"Pt 3","key":"10.1016\/j.tjpad.2024.100040_bib0023","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","article-title":"Dj-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of parkinson's disease","volume":"133","author":"Hong","year":"2010","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100040_bib0024","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13195-024-01463-2","article-title":"Cerebrospinal fluid \u03b1-synuclein adds the risk of cognitive decline and is associated with tau pathology among non-demented older adults","volume":"16","author":"Liu","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"25","key":"10.1016\/j.tjpad.2024.100040_bib0025","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1021\/acs.biochem.9b00215","article-title":"Tau interacts with the c-terminal region of \u03b1-synuclein, promoting formation of toxic aggregates with distinct molecular conformations","volume":"58","author":"Dasari","year":"2019","journal-title":"Biochemistry"},{"issue":"13","key":"10.1016\/j.tjpad.2024.100040_bib0026","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1096\/fj.06-6092com","article-title":"Alpha-synuclein induces hyperphosphorylation of tau in the mptp model of parkinsonism","volume":"20","author":"Duka","year":"2006","journal-title":"Faseb J"},{"issue":"9","key":"10.1016\/j.tjpad.2024.100040_bib0027","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1096\/fj.08-120410","article-title":"Alpha-synuclein contributes to gsk-3beta-catalyzed tau phosphorylation in parkinson's disease models","volume":"23","author":"Duka","year":"2009","journal-title":"Faseb J"},{"key":"10.1016\/j.tjpad.2024.100040_bib0028","doi-asserted-by":"crossref","unstructured":"Tosun D., Hausle Z., Thropp P., et al., Association of csf \u03b1-synuclein seed amplification assay positivity with disease progression and cognitive decline: a longitudinal alzheimer's disease neuroimaging initiative study. medRxiv. 2024. doi: 10.1101\/2024.07.16.24310496.","DOI":"10.1101\/2024.07.16.24310496"},{"issue":"20","key":"10.1016\/j.tjpad.2024.100040_bib0029","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000201202","article-title":"Csf biomarkers of alzheimer disease in patients with concomitant \u03b1-synuclein pathology","volume":"99","author":"Cousins","year":"2022","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100040_bib0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","article-title":"\u0391-synuclein in the pathophysiology of alzheimer's disease","volume":"14","author":"Twohig","year":"2019","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.tjpad.2024.100040_bib0031","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13195-020-00648-9","article-title":"Csf total tau\/\u03b1-synuclein ratio improved the diagnostic performance for alzheimer's disease as an indicator of tau phosphorylation","volume":"12","author":"Shim","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"10.1016\/j.tjpad.2024.100040_bib0032","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0006-8993(00)03082-1","article-title":"Alpha-synuclein-positive structures in cases with sporadic alzheimer's disease: morphology and its relationship to tau aggregation","volume":"888","author":"Arai","year":"2001","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.tjpad.2024.100040_bib0033","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy bodies in alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry","volume":"10","author":"Hamilton","year":"2000","journal-title":"Brain Pathol"},{"issue":"5","key":"10.1016\/j.tjpad.2024.100040_bib0034","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0002-9440(10)65722-7","article-title":"Lewy bodies contain altered alpha-synuclein in brains of many familial alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes","volume":"153","author":"Lippa","year":"1998","journal-title":"Am J Pathol"},{"issue":"21","key":"10.1016\/j.tjpad.2024.100040_bib0035","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","article-title":"Synergistic interactions between abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline","volume":"30","author":"Clinton","year":"2010","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.tjpad.2024.100040_bib0036","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1474-4422(17)30074-1","article-title":"The prognosis of dementia with lewy bodies","volume":"16","author":"Mueller","year":"2017","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.tjpad.2024.100040_bib0037","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson's disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"10.1016\/j.tjpad.2024.100040_bib0038","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.neurobiolaging.2004.10.006","article-title":"Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in lewy body diseases","volume":"26","author":"Pletnikova","year":"2005","journal-title":"Neurobiol Aging"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724006320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724006320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:39:43Z","timestamp":1786023583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724006320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2274580724006320"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2024.100040","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct CSF \u03b1-synuclein aggregation profiles associated with Alzheimer's disease phenotypes and MCI-to-AD conversion","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2024.100040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100040"}}